Visit our Research Page to follow updates and see the published outcomes once available
Clinical trial data from Phase 2 studies involving over 700 participants provides insights into cagrilintide's safety profile
I am so glad I found this company. Your simple 4-step weight-loss plan Take a 5-minute quiz Answer a few questions about your health history and goals, so we can match you with the right program
It contains three different classes of chemical matter that happen to share a cake
They outperformed untreated middle-aged mice
The PIONEER 5 study was a multicenter, double-blind, randomized, placebo-controlled, phase 3a trial where 324 participants, age 18yrs, with type 2 diabetes, HbA1C 7.0-9.0% and moderate renal impairment (eGFR 30-59 mL/min/1.732), were randomly assigned to receive either once-daily oral semaglutide on an empty stomach with up to half a glass of water and 30min before any food/beverage/medication, or placebo for 26 weeks with a follow up period of 5 weeks, with their standard glucose-lowering medication